I haven't looked at Miravant at all but two thoughts about the press release come to mind - the control was a placebo vs. Visudyne and second it doesn't seem they did eye charts to record lines of vision loss or restoration...
I'm curious why this treatment isn't getting more press or as much as Alcon's and DNA's treatment...